ÂÜÀòÂÒÂ×

Susan Dexter serves as Sonnet’s Chief Technical Officer. She comes to Sonnet with more than twenty-five years in biotechnology science, manufacturing, and business development. Susan’s experience includes management of biotechnology contract manufacturing services ranging from process development through commercial manufacturing and strategic consulting-related services. Her prior roles include Managing Director, Latham Biopharm Group, Chief Business Officer at Xcellerex, Inc., VP of Business Development at The Dow Chemical Company, Assoc. Director of Business Development, Celltech and Lonza.

Ms. Dexter holds a double major with Honors in Immunology and Marketing from American University, Washington, D.C.